SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-21-010229
Filing Date
2021-04-29
Accepted
2021-04-29 16:34:18
Documents
4
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A dmtp20210427_10ka.htm 10-K/A 646444
2 EXHIBIT 31.3 ex_244260.htm EX-31.3 5469
3 EXHIBIT 31.4 ex_244261.htm EX-31.4 5365
4 dmtp20210427_10kaimg001.gif GRAPHIC 18246
  Complete submission text file 0001437749-21-010229.txt   683676
Mailing Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address 2 CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36291 | Film No.: 21871276
SIC: 2834 Pharmaceutical Preparations